News Focus
News Focus
icon url

tradeherpete

01/11/24 3:12 PM

#447325 RE: xodcode #447324

Blarcamesine, by any measure is the superior drug for Alzheimer’s and the rest of the CNS unmet need victims.

I agree with you.

Curious that TGD would mention the $14 billion purchase of Karuna unless he thought it was a reasonable valuation benchmark for AVXL.

My goodness, when the market comes to its senses, we will see one HUGE positive price spike in AVXL share price. AZ journal publication, which could happen any time now, will certainly result in a significant upward AVXL price revaluation. OMG $14 billion is one fine AVXL benchmark.

WGT!

icon url

crescentmotor

01/11/24 3:22 PM

#447329 RE: xodcode #447324

Curious that TGD would mention the $14 billion purchase of Karuna unless he thought it was a reasonable valuation benchmark for AVXL.



If nothing else, Missling is sending a message that, although the stock price is very low, don't even think about low balling me. I like that he was ballsy and through out that yardstick.